---
title: "MNPR Q2'26 Earnings: EPS estimate is (0.66) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294954427.md"
description: "MNPR (Monopar Therapeutics Inc.) is set to announce its Q2'26 results on August 06, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.66) USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported—————Revenue Estimate—————Revenue SurpriseEPS Reported(0.35)(0.48)(0.64)(0.46) EPS Estimate(0.46)(0.42)(0.48)(0.72)(0.66) EPS Surprise+23.64%-15.13%-33.01%+36.21%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-08-05T11:01:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294954427.md)
  - [en](https://longbridge.com/en/news/294954427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294954427.md)
generator: "portal-rs"
---

# MNPR Q2'26 Earnings: EPS estimate is (0.66) USD

MNPR (Monopar Therapeutics Inc.) is set to announce its Q2'26 results on August 06, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.66) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

|                      | Q2'25   | Q3'25   | Q4'25   | Q1'26   | Q2'26  |
| -------------------- | ------- | ------- | ------- | ------- | ------ |
| **Revenue Reported** | —       | —       | —       | —       | —      |
| **Revenue Estimate** | —       | —       | —       | —       | —      |
| **Revenue Surprise** |         |         |         |         |        |
| **EPS Reported**     | (0.35)  | (0.48)  | (0.64)  | (0.46)  |        |
| **EPS Estimate**     | (0.46)  | (0.42)  | (0.48)  | (0.72)  | (0.66) |
| **EPS Surprise**     | +23.64% | -15.13% | -33.01% | +36.21% |        |

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [MNPR.US](https://longbridge.com/en/quote/MNPR.US.md)

## Related News & Research

- [Monopar Therapeutics director Raymond Anderson sells USD 349,125 of common shares](https://longbridge.com/en/news/297238555.md)
- [LyondellBasell announces dividend of R$ 1.72 per unit for 3Q 2026](https://longbridge.com/en/news/297814383.md)
- [Americold Realty Trust declares Q3 2026 dividend of R$ 0.27 per unit](https://longbridge.com/en/news/297823075.md)
- [Regeneron announces Q3 2026 dividend of R$ 0.05 per unit](https://longbridge.com/en/news/297814808.md)
- [Gaming and Leisure Properties declares Q3 2026 dividend of $0.82 per share](https://longbridge.com/en/news/297652371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**